Modified Live Herpesvirus Vaccine Shows Protective Qualities Against Neurologic Form
Preliminary research from Cornell University indicates that the commercial vaccine containing weakened live viruses (Rhinomune), called a modified live vaccine (MLV), appears to be more effective in preventing equine herpesvirus (EHV) than kille



